Abrdn Healthcare Investors HQH | NYSE

Dividends

Company Overview:

Market Cap: $1.17B
Trailing PE: —
FWD PE: —
Payout Ratio (TTM): 3.8%
52-Week Range: $17.14 - $24.85

10 Year HQH Performance Metrics:

Total Return (with DRIP): 117.6% (8.09% CAGR)
Total Return (no DRIP): 64.5% (5.11% CAGR)
Share Price: -11.1% (-1.17% CAGR)
Yield on Cost (with DRIP): 26.80%
Total Invested: $10,000
Total Value (with DRIP): $21,758
Total Return $ (with DRIP): $11,758
Dividend Increase: 26.0% (2.40% CAGR)
Dividend Yield (FWD): 12.32% ($2.64)
HQH 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
HQH Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
HQH Price CAGR:1Y: 15.22%2Y: 8.24%5Y: -3.29%10Y: -1.17%
HQH Dividend Charts
HQH - Dividends
HQH Dividend CAGR:1Y: 10.47%2Y: 3.33%5Y: 4.11%10Y: 2.48%
HQH - Dividend Payout Ratio
HQH Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
HQH - Dividend to Free Cash Flow Ratio
HQH Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Build Custom Charts
HQH - Chart 1
HQH - Chart 2
HQH - Chart 3

HQH Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

Revenue
HQH Revenue CAGR:1Y: 541.99%2Y: -17.80%5Y: 0.00%10Y: 0.00%
Earnings Per Share (EPS)
HQH EPS CAGR:1Y: 223.47%2Y: 35.76%5Y: 0.00%10Y: 0.00%
Net Income
HQH Net Income CAGR:1Y: 247.94%2Y: 44.42%5Y: 0.00%10Y: 0.00%
EBITDA
HQH EBITDA CAGR:1Y: 73.97%2Y: 44.42%5Y: 0.00%10Y: 0.00%
Free Cash Flow
HQH Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Free Cash Flow / Share
HQH Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Operating Income
HQH Operating Income CAGR:1Y: 73.97%2Y: 44.42%5Y: 0.00%10Y: 0.00%
Gross Profit
HQH Gross Profit CAGR:1Y: 348.74%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Shares Outstanding
HQH Shares Outstanding CAGR:1Y: 8.22%2Y: 6.45%5Y: 0.00%10Y: 0.00%
Share Buybacks
HQH Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Stock-Based Comp
HQH Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Expenses
HQH Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Revenue vs Net Income
EPS vs FCF / Share
EPS vs PE Ratio
FCF vs FCF / Share
FCF vs Stock Based Comp
Cash & Debt

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

REVENUE: Actual + Estimates
HQH Actual Revenue CAGR:1Y: 541.99%2Y: -17.80%5Y: 0.00%10Y: 0.00%
EPS: Actual + Estimates
HQH Actual EPS CAGR:1Y: 223.47%2Y: 35.76%5Y: 0.00%10Y: 0.00%
NET INCOME: Actual + Estimates
HQH Actual Net Income CAGR:1Y: 247.94%2Y: 44.42%5Y: 0.00%10Y: 0.00%
EBITDA: Actual + Estimates
HQH Actual EBITDA CAGR:1Y: 73.97%2Y: 44.42%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

Net Profit Margin
HQH Net Profit Margin CAGR:1Y: -45.80%2Y: 75.70%5Y: 0.00%10Y: 0.00%
Gross Profit Margin
HQH Gross Profit Margin CAGR:1Y: -30.10%2Y: -5.46%5Y: 0.00%10Y: 0.00%
Price to Earnings
HQH Price to Earnings CAGR:1Y: -65.52%2Y: -24.67%5Y: 0.00%10Y: 0.00%
Price To Sales Ratio
HQH Price To Sales Ratio CAGR:1Y: -81.29%2Y: 32.44%5Y: 0.00%10Y: 0.00%
Return on Capital Employed
HQH Return on Capital Employed CAGR:1Y: 60.08%2Y: 36.55%5Y: 0.00%10Y: 0.00%
Return on Invested Capital
HQH Return on Invested Capital CAGR:1Y: 60.08%2Y: 37.27%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

HQH Dividends Info:

Annual Dividend: $2.64
Forward Yield: 12.32%
Ex-Dividend Date: 2026-08-24
Lifetime Dividends / Share: $62.37

Projected Future Returns & Dividends for HQH

Based on past 10-year performance, here are HQH growth metrics:

Share price CAGR of -1.17%
Dividend CAGR of +2.97%

Using HQH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

HQH (DRIP)HQH - No DRIP
Current Price$21.43$21.43
Start Shares466.64466.64
Start Value$10,000$10,000
  
After 10 years:
Final Share Count2,018.74466.64
Dividends Payment$0.88$0.88
Annual Dividends$7,145$1,651
Yield on cost71.45%16.51%
Share Price$19.06$19.06
Total Dividends$31,021$14,106
Final Value$38,469$22,998

Estimated Future Value + Dividends - HQH

NOTE: Above numbers are our estimate based on HQH's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Abrdn Healthcare Investors (HQH) had its IPO on 1987-04-23, and is traded on NYSE stock exchange.

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

HQH website: https://www.teklacap.com


Loading signals…

DCF Model — HQH

Value from:
Pay up to today
—
vs current price $21.43
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →